topic stringlengths 245 1.29k | doc stringlengths 52 16.9k | label stringclasses 3
values |
|---|---|---|
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Heart Failure Inpatient admission for acute decompensated heart failure Left ventricular systolic or diastolic heart failure Owns a smartphone with a data plan Hospice or life expectancy less than 6 months Palliative inotrope use Heart transplant listed, or status post transplant Ve... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-65.0, Bariatric Surgery Candidate Laparoscopic Sleeve Gastrectomy Obesity, Morbid were, patients between 18 to 65 years old, initial body mass index (BMI) 40 kg/m2 or BMI of 35 kg/m2 in the presence of additional comorbidity and failure of conservative treatment for 2 years None | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Sleep-disordered Breathing Snoring People with Marfan syndrome Age ≥ 18yrs Able and willing to provide informed consent Willing to sleep connected to research apparatus Unstable cardiovascular disease (CHF, myocardial infarction or revascularization procedures, and unstable arrhythm... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation MVARC | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-65.0, Rheumatic Heart Disease Mitral Stenosis Rheumatic Mitral Stenosis Fibrosis; Heart ACE Inhibitor Patients with mitral valve stenosis or a combination aged more than 18 years undergo cardiac valve replacement operation with or without a tricuspid valve repair patients with systolic bloo... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 60.0-85.0, Male Osteoporosis DXA BMD T-score < or = -2.0 at either lumbar spine (LS), femoral neck (FN) or total hip (TH) sites; or DXA BMD T-score < or = -1.5 with at least one additional important clinical risk factor for osteoporotic fracture [e.g., fragility fracture after age 50 years; pare... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Pain, Postoperative Knee Pain Chronic Subjects undergoing TKR Acceptance to participate ASA physical status II-III Age > 18 years Refusal to participate in the study Allergy to local anesthetics History of substance abuse | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 6.0-999.0, Univentricular Heart Children ≥ 6 years old and adults with a single ventricle according to the international classification ACC-CHD and who had a cardiopulmonary exercise test in the year during usual follow-up Patients refuse the use of medical data will be excluded | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation Age ≥ 18 years 2. Moderate-severe or severe mitral regurgitation (> 3+) For Degenerative MR: EROA ≥ 40 mm2 or regurgitant volume ≥ 60ml For Secondary MR: EROA > 30 mm2 or regurgitant volume > 45ml (i.e., MR ≥ moderate-severe or severe by ASE criteria) 3. Patient ... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation Age ≥ 18 years 2. Moderate-severe or severe mitral regurgitation (≥ 3+) 3. Patient has New York Heart Association (NYHA) Functional Class II, III or ambulatory IV 4. Patient is under guideline directed medical therapy, as reviewed and confirmed by the local multi... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation Aortic Regurgitation Age ≥18 years of age Able to give informed consent Referred for isolated aortic or mitral valve repair or replacement due to valve regurgitation Inability to provide consent Pregnancy Claustrophobia Metallic contraindications to MRI (e.g. no... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation Age >=18 yrs 2. able to give informed consent 3. Diagnoses of moderate or severe degenerative mitral regurgitation (based on the integrated approach recommended by the American Society of Echocardiography) Left ventricular ejection fraction <60% 2. Heart failure... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-80.0, Functional Tricuspid Regurgitation Rheumatic mitral valve disease Surgery for mitral valve replacement Severe functional tricuspid regurgitation Moderate functional tricuspid regurgitation with annular dilatation > 40 mm Moderate functional tricuspid regurgitation with preoperative sy... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation Age ≥18 yrs 2. Moderate to severe (3+) or severe (4+) mitral valve regurgitation confirmed by echocardiography (defined as MR >2+); 3. NYHA functional class II-V (Appendix 3); 4. Anatomically suitable for mitral valve repair; 5. 40mm ≤LVESD≤55 mm; 25% ≤LVEF ≤60%;... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-100.0, Pelvic Organ Prolapse Any patient planning to undergo surgery for anterior compartment prolapse, English speaking. - Any patient who does not speak English due to standardized English language based questionaires, and patients without anterior compartment prolapse. - | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation Functional Mitral Valve Disease Cardiovascular Diseases Subject is 18 years of age or older Subject (or legal guardian) understands the trial requirements and the treatment procedures and provides written informed consent before any trial-specific tests or proced... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation Mitral Valve Insufficiency 18 years or older 2. At least moderate to severe symptomatic mitral regurgitation 3. Life expectancy greater than 1 year post intervention 4. Able to give informed consent Patient not eligible for percutaneous mitral valve intervention | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-85.0, Mitral Regurgitation Mitral Insufficiency Signed Informed Consent Form Subject had a successful MAR implantation in clinical investigation 2010-040 Subject is willing to participate in the follow-up study and to comply with the requirements of the Clinical Investigation Plan Subjects... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-89.0, Hip Injuries All patients presenting to Northwestern Memorial Hospital (NMH) or to a Northwestern orthopaedic surgery faculty member's clinic undergoing hip arthroscopy years old or greater Ability to read and speak English Revision surgery Oncologic etiology Arthroscopic hip surgery... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 65.0-999.0, Mitral Valve Regurgitation Severe mitral valve regurgitation ≥ 3+ High surgical risk fot open mitral valve surgery Age ≥ 65 years old Life expectancy > 12 months As assessed by multidisciplinary cardiac team, patients who are not eligible for surgery Patients sign an informed consent... | 1 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 40.0-999.0, Mitral Regurgitation Adults (age ≥ 40 years) with severe, symptomatic primary mitral regurgitation identified by Doppler transthoracic echocardiogram Heart team (cardiologist and cardiac surgeon) agree that patient would be eligible for TMVR with MitraClip TMVR procedure will be perf... | 1 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Systolic Heart Failure Stage D (Disorder) Mitral Regurgitation aged 18 years or older acute decompensated heart failure due to severe left ventricular systolic dysfunction combined with hemodynamically significant mitral regurgitation. Severe systolic dysfunction and hemodynamically ... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation Subjects is eligible to receive the MitraClip per the current approved MitraClip System IFU. (If any update or amendment on the IFU, the latest version of IFU shall be followed.) 2. Subject is 18 years-old or above. 3. Subjects who give consent for study procedur... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 0.0-999.0, Moderate Ischemic Mitral Regurgitation All patient with multi-vessel coronary artery disease with moderate degree of ischemic mitral regurgitation Patient undergone surgery using cardiopulmonary bypass Patient done on elective basis CABG done by off-pump technique patients not candi... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 40.0-85.0, Glaucoma Open-Angle Primary Cataract General 1. Male and female patients, from 40 to 85 years of age, inclusive. 2. Patient is able and willing to attend scheduled follow-up examinations as per routine care for 2 year post-operatively. 3. Patient is able to understand the information ... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 30.0-70.0, Mitral Valve Prolapse Mitral Regurgitation Prolapsed or ruptured chordae Either degenerative or ischemic Patient with redo Mitral Valve surgery Patient with severe rheumatic mitral stenosis (MS) | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 0.0-999.0, Marfan Syndrome Ectopia Lentis MFS patient, clinical diagnosis according to revised Ghent confirmed by FBN1 mutation Relatives of MFS patients with none of the clinical features of MFS and in whom testing for the familial FBN1 mutation was negative Patients who had surgery for ectopi... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 0.0-999.0, Pelvic Organ Prolapse Stage II-IV pelvic organ prolapse Bothersome bulge symptoms At least 725 MET-minutes/week on International Physical Activity Questionnaire Short Form English-speaking Undergoing treatment of prolapse Surgery occurring at least 7 days from date of randomization (t... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-80.0, Tricuspid Regurgitation Severe tricuspid regurgitation, as assessed by the clinical site echocardiographer using the transthoracic echocardiography. 2. A history of LSVS, including one or multiple procedures of aortic and/or mitral valve repair and/or replacement. 3. Left ventricular ... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 21.0-95.0, Mitral Valve Insufficiency Key 1. Moderately severe or severe mitral regurgitation (MR Grade ≥ 3+) 2. Symptomatic mitral regurgitation (NYHA Class II-IV), despite guideline-directed medical therapy (GDMT) determined by the local multidisciplinary heart team 3. Deemed, by the local mul... | 1 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 19.0-999.0, Mitral Valve Insufficiency Mitral Regurgitation Mitral Valve Regurgitation Significant symptomatic mitral regurgitation (MR ≥ 3+) due to primary abnormality of the mitral apparatus [degenerative MR] in patients who have been determined to be at prohibitive risk for mitral valve surge... | 1 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 21.0-999.0, Mitral Regurgitation Each subject is required to meet all of the following 1. Patient is >/= 21 years old. 2. Presence of severe degenerative mitral regurgitation with isolated mid-segment posterior leaflet prolapse by echocardiographic study. 3. Mitral leaflet coaptation surface suf... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation Subject is > 18 years old 2. Presence of severe MR as read on a transthoracic echocardiographic study 3. Mitral leaflet coaptation surface is sufficient to reduce mitral regurgitation without undue leaflet tension (approximate leaflet to gap ratio of 2:1) based o... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Valve Insufficiency Patients with mitral regurgitation that are assigned to the MitraClip implantation by an interdisciplinary heart team according to current guidelines contraindication to MRI examination (e.g. pace-maker, implanted metal material, claustrophobia) pregnancy ... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 0.75-999.0, Chronic Coronary Syndrome Heart Failure AMD and Macular Edema Chronic Respiratory Failure Hemophilia Malignant Hemopathy Multiple Sclerosis Horton's Disease patients with one of the following chronic diseases: chronic coronary syndrome, heart failure, multiple sclerosis, Horton's dis... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Severe Degenerative Mitral Regurgitation Due to Mid-segment Posterior Leaflet Prolapse Subjects who are clinically suitable for treatment with the System, as per the Instructions for Use (IFU), will be evaluated for in the registry N/A | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 22.0-999.0, Ischemic Mitral Regurgitation Functional Mitral Regurgitation Moderate or greater (2+) ischemic Functional Mitral regurgitation by 2D echocardiography using an integrative method Patient is scheduled for cardiac surgery (e.g. CABG including patients on the waiting list for Heart Tran... | 1 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 0.0-70.0, Mitral Prosthetic Valve Stenosis and Regurgitation Age<70 years Symptoms of heart failure NYHA class>ll Severe mitral bioprosthetic dysfunction (stenosis, regurgitation, mixed) defined by echocardiography Heart team (including cardiac surgeon) agree on including assessment that transep... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Residual Tricuspid Regurgitation Left-sided Cardiac Surgery Mitral valve or aortic valve diseases requiring surgical intervention No pathologic changes in TV leaflets No previous tricuspid valve surgery Patients with incomplete data Patient with history of previous cardiac surgery P... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation Surgery Aged at least 18, willing to complete the study follow-up, having signed the informed consent for participation and data management Severe mitral regurgitation due to degenerative disease with indication to mitral repair surgery If of female gender, being... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 20.0-60.0, Probiotics Sub-project 1 Full-time nursing staff from Mackay Memorial Hospital, including wards and special units Age 20 to 60 years old Perceived Stress Scale (PSS) 10 questions version, with a cutoff point of 27 points or more Have taken or are receiving antibiotics within one mont... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation Valve Heart Disease Heart Valve Diseases Mitral Valve Disease Mitral Disease Age 18 years or older. 2. Severe functional mitral regurgitation (≥ Grade 3+). 3. NYHA functional Class ≥ II. If Class IV, patient must be ambulatory. 4. Treatment and compliance with op... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 0.442-0.615, Infant, Premature, Diseases Birth weight between 750 g-1500 g ≤ 32 weeks gestational age at birth. GA will be determined by an ultrasound scan or the neonatologist's estimate, with consideration to maternal date Subject has been classified as appropriate for GA (AGA) Enteral feeding... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 0.083-18.0, Mitral Valve Insufficiency Patients with mitral regurgitation heart disease. 2. Patients with an age range of 1 day years 3. Patients with mitral regurgitation heart disease with atrial septal defects 4. Mitral valve repair surgery performed by single surgeon (Budi Rahmat, MD) Patie... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Valvular Disease Valvular Heart Disease Aortic Valve Stenosis Mitral Insufficiency and Aortic Stenosis Mitral Stenosis Coronary Artery Disease Chronic Kidney Diseases Valvular heart disease in moderate and severe stages Age < 18 years old | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-75.0, Marfan Syndrome patient with Marfan syndrome and followed up at Bichat Claude Bernard hospital, Paris. Marfan syndrome should be diagnosed according to the Ghent nosology revised in 2010 Patient taking protective treatment for the aorta (beta blocker, calcium channel blocker, ACE inhi... | 1 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Covid19 Pregnancy Complications Premature Rupture of Membrane Abruptio Placentae Prelabor Rupture of Membranes Stillbirth - Patients eligible for follow-up o target population will be any pregnant woman who is suspected or needs to be ruled out as having a SARS-CoV-2 infection at any... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 19.0-99.0, Severe Aortic Stenosis or Severe Aortic Regurgitation Age ≥ 19 yrs Severe aortic stenosis or severe aortic regurgitation Agree to consent for self Can follow-up for the next 2 years Pre-existing acute kidney injury Pre-existing end stage kidney disease: estimated glomerular filtratio... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-110.0, Mitral Valve Regurgitation Mitral Valve Stenosis Tricuspid Valve Regurgitation Age above 18 years and consentable Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis Transcatheter mitral or tricuspid valve therapy considered best optio... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-75.0, Heart Failure Part A will healthy men and non-pregnant, non-lactating females of non-childbearing potential with a body mass index (BMI) of 18-30 kg/m^2 and a weight of 60-100 kg. One cohort will require participants be of Japanese descent Part B will men and non-pregnant, non-lactati... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 0.0-999.0, Aortic Stenosis Mitral Regurgitation Pulmonary Hypertension Heart Failure, Systolic Cardiovascular Diseases Coronary Artery Disease Normal Sinus Rhythm LV systolic function >53% Known history of carotid artery disease Moderate or greater valvular disease in Group 1 Other implantable ... | 1 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Tricuspid Regurgitation Pre-Inclusion 1. Age > 18 years 2. Symptomatic secondary (at least) severe TR (Carpentier Type IIIB (restrictive) and / or I (tricuspid annulus dilation)) stable for at least 30 days 3. NYHA functional class II to IV without cirrhosis and/or ascites 4. Signs o... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Tricuspid Regurgitation Tricuspid Valve Insufficiency Heart Valve Interventional treatment of severe tricuspid regurgitation (isolated or in combination with another interventional treatment) with a CE certified product for tricuspid valve repair Informed consent corresponding to of ... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Degenerative Mitral Valve Disease 18 years of age or older 2. Greater than moderate degenerative mitral regurgitation (Grade 3+ or higher) as confirmed by transesophageal echocardiography (TEE) within 90 days prior to study procedure 3. Patient must present with an STS Score less tha... | 1 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Degenerative Mitral Valve Disease 18 years of age or older 2. Greater than moderate degenerative mitral regurgitation (Grade 3+ or higher) as confirmed by transesophageal echocardiography (TEE) within 90 days prior to study procedure 3. Patient must present with an STS Score less tha... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation clinically significant mitral insufficiency patient underwent screening for TMVI echocardiography data at baseline (and after TMVI, E2E and surgery) follow-up of at least 30 days age under 18 years | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Contrast-induced Acute Kidney Injury Acute Coronary Syndromes Urgent or immediate (within 2 hours) coronary procedure with iodinated contrast media administration in the setting of an acute coronary syndrome: ST-Elevation Myocardial Infarction (according to Fourth Universal Definitio... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 20.0-34.0, Child Development Child Obesity Child Behavior Nutritional and Metabolic Diseases Asthma in Children Cardiovascular Risk Factor Bone Loss Not pregnant, resident in Southampton UK GP requested no contact | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 7.0-25.0, Marfan Syndrome Patient aged between 7 and 25 years old with Marfan Syndrome or related according to Ghent For minors, no oral opposition from the holders of parental authority and consent of the minor For adults, no oral opposition collected Patient affiliated to a social security sch... | 1 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-120.0, Surgical Site Infection Risk Assessment Cardiac Surgery >/= 18 years old at the time of surgery; and 2. had a primary surgery (CABG, valve surgery or both) in the UK cardiac centres patients undergoing grown-up congenital heart disease related surgery; 2. patients with concurrent ao... | 1 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Atrial Fibrillation Venous Thromboembolism Heart Valve Diseases At least 18 years of age treated with warfarin for any indication for at least 9 months prior to enrollment Demonstrate the willingness and ability to test their own INR using a home INR monitoring device or have same-da... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-75.0, Mitral Regurgitation Mitral Valve Insufficiency Mitral Valve Prolapse Elective mitral valve repair or replacement Planned minimally invasive approach Non-English speaking Emergency surgery Planned or unplanned sternotomy Previous history of sternotomy and cardiac surgery Allergy to r... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-120.0, Marfan Syndrome Marfan Syndrome Cardiovascular Manifestations >/= 18 years old at the time of surgery Identified MFS in the HES database using the ICD diagnosis code Q874 between January 2010 December 2019 Had an aorto-vascular surgery in England and Wales, as identified in the NICOR... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 60.0-999.0, Mitral Valve Regurgitation Subjects of age ≥ 60 years; 2. Subjects with primary or secondary severe symptomatic mitral valve regurgitation; 3. Subjects with severe, symptomatic mitral regurgitation and who have been evaluated by a multidisciplinary Heart Team and deemed to be ineligi... | 1 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-120.0, Marfan Syndrome Marfan Syndrome Cardiovascular Manifestations >/= 18 years old; 2. have validated diagnosis of MFS (using revised Ghent criteria); 3. diagnosed with aorto-vascular manifestations <18years old 2. Unable or unwilling to give written informed consent. 3. Inability to un... | 1 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-120.0, Marfan Syndrome Marfan Syndrome Cardiovascular Manifestations >/= 18 years old at the time of surgery; 2. have validated diagnosis of MFS (using revised Ghent criteria); 3. having aorto-vascular surgery <18years old at the time of surgery 2. Unable or unwilling to give written infor... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-40.0, Twin Pregnancy; Body Mass Index; Weight Gain; Pregnancy Outcome Age 18 ~ 41 years old The gestational age of the first diagnosed twin pregnancy is ≤10weeks Double chorionic double amniotic sac pregnancy with heart disease, liver disease, kidney disease, complications (chronic hyperte... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Valve Disease Heart Valve Diseases Structural Heart Abnormality adult patients patients admitted to hospital undergoing percutaneous cardiac procedure patients able to give informed consent age <18 years refuse to give informed consent | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 0.0-999.0, Adverse Maternal and Neonatal Outcomes all women presenting for pregnancy-induced hypertension in Renji Hospital Affiliated to Shanghai Jiaotong University from January 2013 to January 2020 cesarean section operation | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-60.0, Obesity BMI over 35 and obesity related disease BMI over 40 age between 18-60 years agrees to participate in the study age under 18 years or over 60 years abundant adhesions discovered during the surgery active upper gastrointestinal ulcer disease prior bariatric surgery active sympt... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Valve Regurgitation Patient is indicated for the Tendyne Mitral Valve System per the Instructions for Use. 2. Patient is willing and able to comply with all follow-up requirements through five years, including study-required testing, medications, and attending all follow-up vi... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Regurgitation Eighteen (18) years of age or greater Moderate to severe (≥3+) or severe (≥4+) mitral valve regurgitation (per American Society of Echocardiography (ASE) guidelines) due to mitral valve prolapse or flail Intermediate or high surgical risk for mitral valve repair ... | 2 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Valve Insufficiency Coronary Artery Disease Patients with severe ischemic Mitral regurgitation (MR), as defined by the 2017 American Society of Echocardiography (ASE) guidelines for noninvasive evaluation of native valvular regurgitation. 2. Presence of reversible myocardial i... | 0 |
34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery. EF of 65% on TTE. Past Medical History: Marfans Syndrome MVP with... | eligible ages (years): 18.0-999.0, Mitral Valve Prolapse Patient over 18 years old Patient with mitral valve prolapse Patient who has received full information about the organization of the research and has signed an informed consent Patient affiliated to or beneficiary of a social security insurance Patient who has c... | 1 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, HER2-negative Breast Cancer HER2-positive Breast Cancer Recurrent Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Histologically confirmed adenocarcinoma of the female breast which is inoperable, recurrent or metastatic HER-2/neu status must be known at the time of prot... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Lymphoma Histologically or cytologically proven HIV-associated B cell non-Hodgkin's lymphoma, including Diffuse large B cell lymphoma Intermediate grade diffuse large cell lymphoma High grade large cell immunoblastic lymphoma Burkitt's lymphoma High grade B cell lymphoma, Burkitt's l... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Distal Urethral Cancer Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Proximal Urethral Cancer Recurrent Bladder Cancer Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Recurrent Urethral Cancer Stage IV Bladder Cancer Transitional Cell Carcinoma ... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 0.0-100.0, Cardiovascular Diseases Heart Diseases Hypertension | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 0.0-70.0, Lymphoma One of the following histologically confirmed diagnoses High grade non-Hodgkin's lymphoma Immunoblastic or small noncleaved cell lymphoma (Burkitt's or non-Burkitt's) in complete or partial remission after initial therapy Localized (stage I or Zeigler stage A) small noncleaved... | 2 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Recurrent Bladder Cancer No concurrent radiotherapy No prior angioplasty No concurrent chemotherapy No concurrent oral or IV corticosteroids for more than 2 consecutive weeks or orally inhaled corticosteroids for more than 4 consecutive weeks during any 6 month period of the study Ch... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 0.0-21.0, Childhood Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia Diagnosis of Philadelphia chromosome positive (Ph+) chronic phase chronic myelogenous leukemia (CML) Stratum I (closed to accrual as of 12/05/03) CML in fir... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 0.0-17.0, Bacterial Infections Other specific inclusion/ may apply. In order to determine further examination by the investigator is necessary Hospitalized/chronic care pediatric patients (birth through 17 years) Known infections due to vancomycin-resistant enterococcus species, including diagn... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Urinary Tract Infections SCI UTI | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Ileus Neoplasms Previous surgical cancer treatment with ileostomy/colostomy, now scheduled for closure Hospital admission must be same day as surgery Incapacitating disease Concurrent herbal or laxative use Use of Heparin or Coumadin Upper or lower extremity deformities Chronic cons... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 19.0-999.0, Urinary Tract Infection At least two UTIs in the year prior to study entry Willing to use acceptable methods of contraception Willing to refrain from consuming other forms of cranberry supplementation Current UTI Allergy to cranberry-containing products Active urinary stone disease ... | 1 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Stomatitis Male or female patients ages > 18 yrs Patients undergoing high dose chemotherapy with or without radiation therapy treatment as conditioning for autologous hematopoietic stem cell transplantation. The conditioning regimens at least one of the following: high dose melphalan... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lympho... | 1 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Urinary Tract Infection Bacteriuria Urethral catheter in situ for at least 3 days (72h) Pregnancy Impaired renal or hepatic function (serum creatinine > 150 mmol/l, serum transaminases > 75 IU/l) Fever Symptomatic urinary tract infection Antibiotic use ≤ 48 hours before urinary cath... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Hepatitis B, Chronic Hepatitis C, Chronic Male and female patients >= 18 years of age will be recruited Patients with dual chronic hepatitis C and B must be positive for both anti-HCV and HBsAg for more than 6 months and HCV RNA quantifiable at 600 IU/mL (by the COBAS HCV Test versi... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 5.0-999.0, Hemophilia A Age >= 5 years The subject has severe or moderately severe hemophilia A defined by a baseline factor VIII level <= 2% of normal documented at screening or historically (e.g., at hemophilia diagnosis) Subjects may enroll regardless of their serologic status for human immun... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 40.0-95.0, COPD Subject is able to ambulate. Defined as a 6MWD greater than 110 meters Subject is diagnosed with COPD years-old and older Currently or previously smoking with a smoking history of at least 10 pack-years Forced expiratory volume on one second (FEV1) after the use of a bronchodilat... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-70.0, Chronic Hepatitis C All eligible adult patients with compensated liver disease due to chronic infection with HCV and genotype 1 infection who are treatment naïve will be enrolled into the study All racial and ethnic groups will be recruited into this study Males and females: age > 18 ... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 16.0-999.0, Urinary Infections Hospitalized patients over 16 years of age with complicated urinary infection produced by bacteria that are suspected to be susceptible to treatment with Piperacillin-tazobactam Patients known, or thought to be hypersensitivity to beta-lactams Patients with an unc... | 2 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Urinary Tract Infections Pyelonephritis Positive dipstick test for leukocyte esterase AND/OR at least 5 white blood cells per centrifuged urine sediment AND/OR at least 10 white blood cells per microliter of uncentrifuged urine outpatient or inpatient (in hospital, nursing home, or o... | 1 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Urinary Tract Infections Pyelonephritis Diagnosis of complicated lower urinary tract infection or pyelonephritis Women who are pregnant, nursing or of child-bearing potential and not using a medically accepted, effective method of birth control History of moderate or severe hypersen... | 2 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 60.0-85.0, Idiopathic Normal Pressure Hydrocephalus Patients who had at least one more points of the triad (gait disturbance, cognitive impairment, and urinary incontinence) in Japan NPH grading scale revised, and had disproportionate ventriculomegaly (Evans index >0.3) with closing of the CSF s... | 0 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Urinary Tract Infections Pyelonephritis Diagnosis of complicated lower urinary tract infection or pyelonephritis Women who are pregnant, nursing or of child-bearing potential and not using a medically accepted, effective method of birth control History of moderate or severe hypersen... | 2 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Urinary Tract Infections Bacteriuria Urologic Diseases Pyelonephritis Neurogenic Bladder Diagnosis of a urinary tract infection with complicating factors such as anatomical or functional abnormalities capable of taking medication by mouth previous antibacterial therapy of less than 2... | 1 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-999.0, Urinary Tract Infections Bacterial Infections Bacteriuria Urologic Diseases Diagnosis of a urinary tract infection with complicating factors such as anatomical or functional abnormalities capable of taking medication by mouth previous antibacterial therapy of less than 24 hours, or p... | 1 |
62 yo male with hx of CVA, neurogenic bladder with indwelling suprapubic catheter with multiple prior admissions for UTIs, altered mental status, and urosepsis presents to the hospital in urosepsis now resolved after treatment with vanc/meropenem. Per CT there is a non-obstructing stone in the L ureter, no evidence of ... | eligible ages (years): 18.0-75.0, Recurrent Urinary Tract Infections in Women Three or more urinary tract infections in the previous year Neurogenic bladder Interstitial cystitis Urinary diversion Kidney stones Indwelling catheter | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.